🇺🇸 FDA

Drug profile · INN

potassium phosphate, dibasic

POTASSIUM PHOSPHATES

FDA: approved
US status
approved
Patents linked
0
News articles
0

Quick answer

potassium phosphate, dibasic (POTASSIUM PHOSPHATES) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: intravenous. Current US regulatory status: approved.

Key facts

INN potassium phosphate, dibasic
Brand POTASSIUM PHOSPHATES
Route INTRAVENOUS
Formulation SOLUTION
Originator Regeneron Ireland Designated Activity Company (DAC)

Frequently asked questions

What is potassium phosphate, dibasic?

potassium phosphate, dibasic (POTASSIUM PHOSPHATES) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: intravenous. Current US regulatory status: approved.

What is the brand name for potassium phosphate, dibasic?

POTASSIUM PHOSPHATES is a marketed brand name for potassium phosphate, dibasic. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of potassium phosphate, dibasic?

potassium phosphate, dibasic has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.